文献速递眼底病与葡萄膜炎

膜联蛋白A1作为糖尿病视网膜病变炎症、胶质与血管生成信号通路的关键调节因子

Annexin A1 as a Key Modulator of Inflammatory, Glial, and Angiogenic Signaling Pathways in Diabetic Retinopathy.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

该研究在链脲佐菌素诱导的糖尿病视网膜病变(DR)小鼠模型中,比较野生型(AnxA1+/+)与AnxA1敲除(AnxA1-/-)小鼠,发现AnxA1缺失加重选择性全身炎症改变、促进视网膜神经退行性变,并伴随促血管生成信号谱。结论提示内源性AnxA1调节糖尿病视网膜的炎症-胶质与促血管生成信号通路。

要点

  • AnxA1缺失加重DR小鼠选择性全身炎症和视网膜神经退行性变。
  • AnxA1-/-糖尿病动物循环IL-6、IL-17、CXCL1、MCP-1升高,视网膜MCP-1和IL-4上调。
  • AnxA1缺失伴随MAPK/STAT3信号失调、胶质反应改变及视网膜EGF、VEGF-A、内皮素-1升高。

核心结论

  • 内源性AnxA1调节糖尿病视网膜的炎症-胶质与促血管生成信号通路。
  • AnxA1缺失与DR进展中选择性炎症失调和血管生成相关信号增强相关。

研究设计与样本

  • 在野生型(AnxA1+/+)和AnxA1敲除(AnxA1-/-)小鼠链脲佐菌素注射后12周诱导DR模型。
  • 评估AnxA1缺失对DR相关视网膜形态、Müller细胞活化、炎症和血管生成的影响。
  • 对诱导6周的野生型DR动物及DR患者数据集进行in silico分析。
  • 采用脉络膜新生血管模型评估AnxA1在血管生成信号中的作用。

主要发现

  • AnxA1缺失加重选择性全身炎症改变并促进DR相关视网膜神经退行性变。
  • AnxA1-/-糖尿病动物循环IL-6、IL-17、CXCL1和MCP-1水平升高,视网膜MCP-1和IL-4上调。
  • AnxA1-/-糖尿病动物出现MAPK/STAT3信号失调和胶质反应改变。
  • AnxA1缺失与DR中视网膜EGF、VEGF-A和内皮素-1水平升高这一促血管生成信号谱相关。
  • VEGF-C上调主要见于脉络膜新生血管模型。

临床怎么用

  • AnxA1可作为理解DR炎症-胶质与促血管生成信号交叉调控的候选分子靶点。
  • AnxA1缺失相关的外周IL-6、IL-17、CXCL1、MCP-1及视网膜MCP-1、IL-4、EGF、VEGF-A、内皮素-1变化可为DR生物标志与机制研究提供线索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Annexin A1 (AnxA1) regulates inflammation and neovascularization in ocular diseases, influencing growth factor signaling and cytoskeletal dynamics. Accordingly, this study aimed to investigate the role of the AnxA1 protein in diabetic retinopathy (DR) and to understand how its absence affects inflammation and vascular dysfunction in DR. METHODS: DR model was induced 12 weeks after streptozotocin injection in wild-type (AnxA1+/+) and AnxA1 knockout (AnxA1-/-) mice. We evaluated the consequences of AnxA1 deficiency on retinal morphology, Müller cell activation, inflammation, and angiogenesis associated with DR. We also performed an in silico analysis in wild-type animals with DR induced for 6 weeks and in a dataset of patients with DR. Furthermore, a choroidal neovascularization model was used to evaluate the role of AnxA1 in angiogenesis signaling. RESULTS: AnxA1 deficiency exacerbated selective systemic inflammatory alterations and promoted retinal neurodegeneration associated with DR. AnxA1-/- diabetic animals exhibited increased circulating IL-6, IL-17, chemokine (C-X-C motif) ligand 1, and monocyte chemoattractant protein-1 levels, retinal monocyte chemoattractant protein-1 and IL-4 upregulation, dysregulated MAPK/STAT3 signaling, and altered gliosis responses. In addition, AnxA1 deficiency was associated with a proangiogenic signaling profile characterized by increased retinal levels of EGF, VEGF-A, and endothelin-1 in DR, whereas the upregulation of VEGF-C was predominantly observed in the choroidal neovascularization model. CONCLUSIONS: Endogenous AnxA1 modulates inflammatory-glial and proangiogenic signaling pathways in the diabetic retina. Its deficiency is associated with selective inflammatory dysregulation and enhanced angiogenesis-related signaling during DR progression.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. da Silva RA, Ferreira LPS, Roda VMP, et al. Annexin A1 as a Key Modulator of Inflammatory, Glial, and Angiogenic Signaling Pathways in Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2026. PMID: 42554407. doi:10.1167/iovs.67.10.12

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。